Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04478279
Title A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sapience Therapeutics
Indications

progesterone-receptor positive breast cancer

carcinoma

melanoma

estrogen-receptor positive breast cancer

glioblastoma

sarcoma

prostate cancer

Therapies

ST-101

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.